NASDAQ:XLO | EBITDA Margin | Xilio Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-108.86%
2025-12-31-84.12%
2025-03-31-455.77%
2024-12-31-768.74%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-92.40%
2024-12-31-929.04%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.